Pfizer Raises Sales Forecast for COVID-19 Biologic to $33.5 Billion in 2021
![Pfizer Raises Sales Forecast for COVID-19 Biologic to .5 Billion in 2021 Pfizer Raises Sales Forecast for COVID-19 Biologic to .5 Billion in 2021](https://thevaccinereaction.org/wp-content/uploads/2021/08/revenue.png)
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of this year raising the company’s 2021 sales forecast for the two-dose vaccine to $33.5 billion from the previously estimated $26 billion.1 The $7.8 billion from direct sales of the shot is split with its German […]